Ledger.Open graph →
SEC Form D · filed April 8, 2015

Gemphire Therapeutics Inc

Offering
$3.0M
Sold
$2.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Northville, MI
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Mina Sooch · Northville, MIExecDavid Lowenschuss · Northville, MIExecMargaret Mcshane · Northville, MIExecCharles Bisgaier · Northville, MIExecP. K. Hawryluk · Carmel, INDirectorDaniela Oniciu · Northville, MIExecAmy Zaremba Rabourn · Northville, MIDirectorStephen Haakenson · Kalamazoo, MIDirectorAmir Belson · Menlo Park, CAExecDeborah L. Machovec · Wahoo, NEDirectorLawrence Chavez · Albuquerque, NMExecWilliam Alaynick · San Diego, CAExecKenneth Hood · San Diego, CAExecMarc A. Weiser · Ann Arbor, MIExecPravin V. Gandhi · Fort Mumbai, K7ExecBala V. Deshpande · Timonium, MDExecGeorge A. Parris · Audubon, IAExec · DirectorJon Cheek · SAN FRANCISCO, CAExec · DirectorScott D. Shallo · Kinderhook, NYDirectorJt Michelson · Albuquerque, NMExecStephen Haakenson · Kalamazoo, MIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗